STOCK TITAN
  1. Home
  2. Sec-filings
  3. OSCR
  4. [8-K] Oscar Health, Inc. Reports Material Event

Oscar Health (NYSE: OSCR) to reaffirm 2026 outlook at GS event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Oscar Health, Inc. announced it will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026, where it plans to provide a business update and reaffirm its full year 2026 guidance previously issued on February 10, 2026.

A live audio webcast will be available on the company’s investor relations website, with a replay accessible for about 90 days. The company also reminds readers that statements about expected financial performance are forward-looking and subject to risks described in its Form 10-K for 2025 and Form 10-Q for the quarter ended March 31, 2026.

Positive

  • None.

Negative

  • None.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Regulation FD regulatory
"Item 7.01. Regulation FD Disclosure. Oscar Health, Inc. (the “Company”)"
Regulation FD is a rule that prevents company insiders, like executives, from sharing important information with some people before others get it. It matters because it helps ensure all investors have equal access to key news, making the stock market fairer and reducing chances of insider trading.
full year 2026 guidance financial
"provide a business update and reaffirm its full year 2026 guidance"
forward-looking statements regulatory
"contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Annual Report on Form 10-K regulatory
"factors set forth under the caption “Risk Factors” in our Annual Report on Form 10-K"
An annual report on Form 10‑K is a required, comprehensive filing that publicly traded companies give to regulators and investors summarizing their business, results of operations, detailed financial statements reviewed by independent auditors, material risks, legal issues and management’s discussion of performance. Investors use it like a company’s year‑end report card and medical checkup: it reveals how the business made money, where it is vulnerable, and the facts needed to compare value, judge risk and make informed investment decisions.
Quarterly Report on Form 10-Q regulatory
"including our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2026"
A quarterly report on Form 10-Q is a standardized financial filing public companies must submit to U.S. regulators every three months, summarizing recent financial results, cash flows, balance sheet changes, operations and material risks or legal developments. Investors treat it like a company report card that shows up-to-date facts rather than marketing copy, helping them track performance, spot trends, reassess risk and make buy or sell decisions.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →
0001568651FALSE00015686512026-06-082026-06-08

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): June 8, 2026
Oscar Health, Inc.
(Exact Name of Registrant as Specified in its Charter)
Delaware001-4015446-1315570
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)

75 Varick Street, 5th Floor
New York, New York 10013
(Address of Principal Executive Offices) (Zip Code)
(646) 403-3677
(Registrant’s telephone number, including area code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbols
Name of each exchange
on which registered
Class A Common Stock, $0.00001 par value per shareOSCRNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 7.01. Regulation FD Disclosure.

Oscar Health, Inc. (the “Company”) will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference (the “Conference”) on June 8, 2026 at approximately 11:20 AM ET. At the Conference, the Company plans to provide a business update and reaffirm its full year 2026 guidance, as previously provided in its financial results press release dated February 10, 2026. A live audio webcast will be available via the Investor Relations page of the Company’s website at ir.hioscar.com, and a replay will be available for approximately 90 days following the event.

This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in any such filing.

Cautionary Note Regarding Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained herein are forward- looking statements. These statements include, but are not limited to, statements about our expected financial performance and upcoming events and presentations. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions, and uncertainties that are difficult to predict and generally beyond our control. Although management believes that the expectations reflected in these forward-looking statements are reasonable as of the date made, there are or will be important factors that could cause our actual results to differ materially from those indicated in these forward-looking statements, including, but not limited to, the factors set forth under the caption “Risk Factors” in our in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission (“SEC”), and our other filings with the SEC, including our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2026, filed with the SEC.

You are cautioned not to place undue reliance on any forward-looking statements made in this Form 8-K. Any forward-looking statement speaks only as of the date as of which it is made, and, except as otherwise required by law, we do not undertake any obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise. New factors emerge from time to time, and it is not possible for us to predict which will arise.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Oscar Health, Inc.
By:/s/ R. Scott Blackley
Name:R. Scott Blackley
Title:Chief Financial Officer
Date: June 8, 2026

Source: View Original Filing on SEC EDGAR

FAQ

What did Oscar Health (OSCR) disclose in this 8-K filing?

Oscar Health disclosed it will join a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference and plans to provide a business update and reaffirm full year 2026 guidance originally issued on February 10, 2026, during that appearance.

When will Oscar Health (OSCR) reaffirm its 2026 guidance?

Oscar Health intends to reaffirm its full year 2026 guidance during a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026, at approximately 11:20 AM ET, alongside a broader business update presentation.

How can investors access Oscar Health’s Goldman Sachs conference presentation?

Investors can access a live audio webcast of Oscar Health’s fireside chat via the Investor Relations section of its website at ir.hioscar.com, with a replay available for approximately 90 days following the event for those unable to listen live.

Does this Oscar Health 8-K contain forward-looking statements?

Yes. The company states the communication includes forward-looking statements about expected financial performance and events, which are subject to risks and uncertainties described in its Form 10-K for 2025 and Form 10-Q for the quarter ended March 31, 2026.

Is the information in this Oscar Health 8-K considered filed with the SEC?

The company specifies this information is not deemed filed under Section 18 of the Exchange Act and is not incorporated by reference into Securities Act or Exchange Act filings unless specifically referenced, limiting potential liability associated with these disclosures.

Where does Oscar Health direct investors for risk factor details?

Oscar Health directs investors to the “Risk Factors” section in its Annual Report on Form 10-K for the year ended December 31, 2025, and to other SEC filings, including its Form 10-Q for the quarter ended March 31, 2026, for detailed risk discussions.

Filing Exhibits & Attachments

3 documents

Other Documents